148 related articles for article (PubMed ID: 38348660)
1. Immunocapture LC-MS methods for pharmacokinetics of large molecule drugs.
Werth EG; Roos D; Philip ET
Bioanalysis; 2024 Apr; 16(7):165-177. PubMed ID: 38348660
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on potentiating immunocapture-LC-MS for the bioanalysis of biotherapeutics and biomarkers.
Sugimoto H; Wei D; Dong L; Ghosh D; Chen S; Qian MG
Bioanalysis; 2018 Oct; 10(20):1679-1690. PubMed ID: 30371100
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Characterization and Tissue Distribution of Fusion Protein Therapeutics by Orthogonal Bioanalytical Assays and Minimal PBPK Modeling.
Sugimoto H; Chen S; Qian MG
Molecules; 2020 Jan; 25(3):. PubMed ID: 31991858
[TBL] [Abstract][Full Text] [Related]
4. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
[TBL] [Abstract][Full Text] [Related]
5. Critical considerations for immunocapture enrichment LC-MS bioanalysis of protein therapeutics and biomarkers.
Zhao Y; Gu H; Zheng N; Zeng J
Bioanalysis; 2018 Jul; 10(13):987-995. PubMed ID: 29972311
[TBL] [Abstract][Full Text] [Related]
6. The role of ligand-binding assay and LC-MS in the bioanalysis of complex protein and oligonucleotide therapeutics.
Kotapati S; Deshpande M; Jashnani A; Thakkar D; Xu H; Dollinger G
Bioanalysis; 2021 Jun; 13(11):931-954. PubMed ID: 33998268
[TBL] [Abstract][Full Text] [Related]
7. Immunocapture LC-MS(/MS) assays for biotherapeutic and biomarker proteins: the European Bioanalysis Forum continuing discussions on scientific and regulatory challenges.
Barfield M; Blackburn M; Blattmann P; Ingelse B; Jordan G; Fusetti F; Gnoth MJ; Sporring SH; Love I; Muccio S; de Merbel NV; Wheller R; Wilson A; Timmerman P
Bioanalysis; 2023 May; 15(9):477-480. PubMed ID: 37318068
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
9. Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays.
Wang J; Gu H; Liu A; Kozhich A; Rangan V; Myler H; Luo L; Wong R; Sun H; Wang B; Vezina HE; Deshpande S; Zhang Y; Yang Z; Olah TV; Aubry AF; Arnold ME; Pillutla R; DeSilva B
Bioanalysis; 2016 Jul; 8(13):1383-401. PubMed ID: 27277879
[TBL] [Abstract][Full Text] [Related]
10. 2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).
Gupta S; Richards S; Amaravadi L; Piccoli S; Desilva B; Pillutla R; Stevenson L; Mehta D; Carrasco-Triguero M; Neely R; Partridge M; Staack RF; Zhao X; Gorovits B; Kolaitis G; Sumner G; Stubenrauch KG; Zou L; Amur S; Beaver C; Berger I; Berisha F; Birnboeck H; Bower J; Cho SJ; Cludts I; Cocea L; Donato LD; Fischer S; Fraser S; Garofolo F; Haidar S; Haulenbeek J; Hottenstein C; Hu J; Ishii-Watabe A; Islam R; Jani D; Kadavil J; Kamerud J; Kramer D; Kurki P; MacMannis S; McNally J; Mullan A; Papadimitriou A; Pedras-Vasconcelos J; Ray S; Safavi A; Saito Y; Savoie N; Fjording MS; Scheibner K; Smeraglia J; Song A; Stouffer B; Tampal N; der Strate BV; Verch T; Welink J; Xu Y; Yang TY; Yengi L; Zeng J; Zhang Y; Zhang Y; Zoog S
Bioanalysis; 2017 Dec; 9(24):1967-1996. PubMed ID: 29205064
[TBL] [Abstract][Full Text] [Related]
11. 2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis).
Welink J; Xu Y; Yang E; Wilson A; Henderson N; Luo L; Fraser S; Kavita U; Musuku A; James C; Fraier D; Zhang Y; Goykhman D; Summerfield S; Woolf E; Verhaeghe T; Hughes N; Behling A; Brown K; Bulychev A; Buonarati M; Cherry E; Cho SJ; Cludts I; Dillen L; Dodge R; Edmison A; Garofolo F; Green R; Haidar S; Hottenstein C; Ishii-Watabe A; Jang HG; Ji A; Jones B; Kassim S; Ma M; Lima Santos GM; Norris DA; Owen T; Piccoli S; Ramanathan R; Röhl I; Rosenbaum AI; Saito Y; Sangster T; Savoie N; Stebbins C; Sydor J; de Merbel NV; Verthelyi D; Vinter S; Whale E
Bioanalysis; 2018 Nov; 10(22):1781-1801. PubMed ID: 30488725
[TBL] [Abstract][Full Text] [Related]
12. ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates.
Mou S; Huang Y; Rosenbaum AI
Antibodies (Basel); 2018 Nov; 7(4):. PubMed ID: 31544891
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM.
Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI
Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773
[TBL] [Abstract][Full Text] [Related]
14. Fit-for-purpose protein biomarker assay validation strategies using hybrid immunocapture-liquid chromatography-tandem-mass spectrometry platform: Quantitative analysis of total soluble cluster of differentiation 73.
Zhao Y; Gu H; Postelnek J; DeMichele M; Yuan L; Zhang YJ; Zeng J
Anal Chim Acta; 2020 Aug; 1126():144-153. PubMed ID: 32736718
[TBL] [Abstract][Full Text] [Related]
15. Critical reagent screening and characterization: benefits and approaches for protein biomarker assays by hybrid LC-MS.
Santockyte R; Zeng J; Zheng N
Bioanalysis; 2019 Apr; 11(8):785-795. PubMed ID: 30994008
[TBL] [Abstract][Full Text] [Related]
16. LC-MS quantification of protein drugs: validating protein LC-MS methods with predigestion immunocapture.
Duggan J; Ren B; Mao Y; Chen LZ; Philip E
Bioanalysis; 2016 Sep; 8(18):1951-64. PubMed ID: 27532431
[TBL] [Abstract][Full Text] [Related]
17. Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibody.
Law WS; Genin JC; Miess C; Treton G; Warren AP; Lloyd P; Dudal S; Krantz C
Bioanalysis; 2014; 6(23):3225-35. PubMed ID: 25529889
[TBL] [Abstract][Full Text] [Related]
18. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
Duggan JX
Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
[No Abstract] [Full Text] [Related]
19. A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study.
Chen LZ; Roos D; Philip E; Werth EG; Kostuk S; Yu H; Fuchs H
Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399408
[TBL] [Abstract][Full Text] [Related]
20. Bioanalytical strategy for the characterization and bioanalysis of biologics: a global, nonregulated bioanalytical lab perspective.
Sarvaiya H; Niu S; Ladror DT; Wang Y; Maji D; Wolke M; Natarajan P; Jenkins GJ
Bioanalysis; 2023 Feb; 15(3):133-148. PubMed ID: 36891956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
